For accurate and reliable results, choose plasma-EDTA for all our tests. Plasma, preserved with EDTA, maintains the integrity of your biomarker analysis by preventing clotting and reflecting the true state of the circulating immune environment. Unlike serum, in which inflammatory factors can be released during clotting (1), plasma provides a more precise snapshot. Plus, since specific reference intervals for serum haven’t been established for several tests, using plasma-EDTA avoids the risk of sample rejection and ensures the highest quality data.
Serum amyloid is simply a universal convention to distinguish the Amyloid A we detect as being in biological fluids (typically serum or plasma), and not from cellular or tissue extracts for example. Plasma-EDTA is the preferred sample type for SAA testing.
For optimal accuracy in your results, it is crucial to freeze samples promptly within 30 minutes of collection and minimize freeze-thaw cycles to preserve analyte integrity (1). To ensure your samples are handled with the utmost care, follow our comprehensive Sample Collection Guide and Shipping Guide. These resources provide step-by-step instructions to help you maintain the highest standards in sample integrity.
We pride ourselves on a rapid turnaround time, with results typically delivered within 5 business days of receiving your specimen and payment. With our commitment to precision and efficiency, you can count on us to provide the insights you need, promptly and accurately.
The LDT (Lab Developed Test) designation highlights that our tests are regulated by the Centers for Medicare & Medicaid Services (CMS) under CLIA, ensuring they meet stringent quality and accuracy standards. Unlike commercially distributed tests, which undergo FDA approval, our LDTs are developed and validated within our laboratory to provide specialized and reliable diagnostic insights tailored to your needs. This distinction underscores our commitment to maintaining the highest standards in testing and personalized care.